S-1: Greenlane Holdings Eyes $11.8 Million Boost Through Warrant Exercises; Selling Stockholders Plan Resale

Greenlane Holdings anticipates a potential $11.8 million influx from warrant exercises as selling stockholders register to resell over 7 million shares of common stock.

Summary

• Greenlane Holdings has filed a registration statement for the offering and resale of up to 7,090,911 shares of common stock by selling stockholders.
• These shares include 58,000 shares of common stock, 2,305,637 shares issuable upon exercise of pre-funded warrants, and 4,727,274 shares issuable upon exercise of outstanding warrants.
• The company will not receive any proceeds from the sale of these shares by the selling stockholders.
• However, Greenlane could receive approximately $11,820,490 upon the cash exercise of common warrants and prefunded warrants.
• The selling stockholders may sell their shares directly or through underwriters, broker-dealers, or agents.
• Greenlane will bear all fees and expenses related to registering the common stock.
• The last reported sale price of Greenlane's common stock on The Nasdaq Global Market on August 26, 2024, was $6.25 per share.
• Investing in Greenlane's securities involves a high degree of risk, as detailed in the Risk Factors section of the prospectus.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While there's potential for revenue from warrant exercises and strategic initiatives, the company faces significant financial risks, regulatory challenges, and market uncertainties, leading to a cautious outlook.

Positives

• Potential influx of $11.8 million if all warrants are exercised, which could be used for general corporate purposes and capital expenditures.
• The company has a PACT Act Exemption, allowing it to ship vaporizers and accessories classified as electronic nicotine delivery systems (ENDS) products to other compliant businesses.
• The company has been consolidating and streamlining its warehouse and distribution in 2023, which should improve operational efficiency.
• The company is focused on converting more of its overall sales to be completed through technology platforms such as its e-commerce consumer sites, large marketplace sites like Amazon, and its proprietary B2B ordering portal at Wholesale.Greenlane.com.

Negatives

• The company will not receive any proceeds from the sale of shares by the selling stockholders.
• Investing in Greenlane's securities involves a high degree of risk.
• The company has experienced significant turnover in its executive leadership in recent years.
• The company has failed, and may continue to fail, to meet the listing standards of Nasdaq, and as a result its Class A common stock may become delisted, which could have a material adverse effect on the liquidity of our Class A common stock.

Risks

• Global economic conditions, including inflation and supply chain disruptions, could materially and adversely affect the business.
• The company's ability to fund its capital requirements depends on increasing sales, raising capital, and generating positive cash flow.
• Failure to meet Nasdaq listing standards could result in delisting, negatively impacting the stock price and liquidity.
• Narrow margins may magnify the impact of variations in operating costs and unforeseen events.
• The market for vaporizer products is a niche market subject to uncertainty and evolving regulations.
• The company depends on third-party suppliers and may experience supply shortages.
• A significant percentage of revenue is dependent on sales of products from a relatively small number of key suppliers.
• There is uncertainty related to the regulation of vaporization products and certain other consumption accessories.
• Demand for the products the company distributes could decrease if the trend of suppliers selling products directly to consumers or retailers continues or accelerates.
• The company is vulnerable to third-party transportation risks, including governmental laws and common carriers policies that prevent the shipment of the types of products it sells.
• The company does not have long-term agreements or guaranteed price or delivery arrangements with most of its suppliers.
• The company does not have long-term contracts with many of its customers.
• Changes in the customer, product or competition mix could cause the product margin and results of operations to fluctuate.
• The company's principal asset is its interest in the Operating Company, and, accordingly, it depends on distributions from the Operating Company to pay its taxes and expenses.
• The Tax Receivable Agreement (the TRA) may require the company to make cash payments to the members of the Operating Company in respect of certain tax benefits to which it may become entitled.
• If the company were deemed to be an investment company under the U.S. Investment Company Act of 1940, as amended (the 1940 Act), as a result of its ownership of the Operating Company, applicable restrictions could make it impractical for the company to continue its business as contemplated and could have a material adverse effect on its business.
• The market price of the company's Class A common stock has been volatile and has declined significantly since its initial public offering and may face more volatility and price declines in the future.
• As a public reporting company, the company is subject to rules and regulations established from time to time by the SEC regarding its internal control over financial reporting.
• The company may issue shares of preferred stock in the future, which could make it difficult for another company to acquire it or could otherwise adversely affect holders of its Class A common stock, which could depress the market price of its Class A common stock.
• The company's amended and restated certificate of incorporation and bylaws provide that the Court of Chancery of the State of Delaware is the sole and exclusive forum for substantially all disputes between the company and its stockholders, which could limit its stockholders ability to obtain a favorable judicial forum for disputes with the company or its directors, officers or employees.
• The company is a smaller reporting company under federal securities laws and it cannot be certain whether the reduced reporting requirements applicable to such companies will make its Class A common stock less attractive to investors.

Future Outlook

Greenlane intends to leverage its competitive strengths to increase shareholder value through core strategies, including accelerating the path to profitability, capitalizing the business, and developing a world-class portfolio of products.

Management Comments

• Management believes that technology enhancements, facility footprint rationalization, headcount reduction, cost structure optimization, inventory management, sales force upgrade, product innovation, and capital investment will significantly reduce costs, help accelerate the Company's path to profitability, support business growth, and allow the Company to reinvest capital into its highest demand and highest potential product lines.

Industry Context

The document provides an overview of the cannabis industry landscape in North America and Europe, highlighting legislative changes, market growth, and consumer trends. It notes the increasing legalization of cannabis in various regions and the potential for market expansion.

Comparison to Industry Standards

• The document mentions the growth of the legal cannabis market in the United States, citing a growth from $26.5 billion in 2022 to $31.4 billion in 2023.
• It also notes the growth of the Canadian market from CAD 4.8 billion in 2022 to CAD 5.6 billion in 2023.
• The European cannabis market is expected to grow to approximately $6.2 billion in annual sales in 2024, a significant growth from approximately $3.7 billion in 2023.

Management Changes

Legal Proceedings

• On February 8, 2023, the company filed a lawsuit against Blum in Superior Court of California, Orange County, seeking to compel the repayment of Blum's open balance due to the company.

Related Party Transactions

• Nicholas Kovacevich, the company's former Chief Corporate Development Officer, owns capital stock of Blum Holdings Inc. (Blum) and serves on the Blum board of directors.
• Adam Schoenfeld, co-founder and a former director of the company, has a significant ownership interest in one of the company's customers, Universal Growing.
• Renah Persofsky, a director of the company, is a member of the board of directors of Tilray Brands, Inc. (Tilray).

Stakeholder Impact

• Shareholders face risks related to stock volatility, potential dilution, and the company's ability to meet Nasdaq listing requirements.
• Employees may be affected by cost-cutting measures, including headcount reductions.
• Customers may experience changes in product availability and pricing due to supply chain disruptions and regulatory developments.
• Suppliers may be impacted by the company's financial condition and ability to maintain payment terms.

Next Steps

• Selling stockholders may sell all or a portion of the shares of common stock beneficially owned by them and offered hereby from time to time directly or through one or more underwriters, broker-dealers or agents.
• The company will continue to implement its remediation plan to address the identified material weaknesses, and its management continues to be actively engaged in the remediation efforts.

Key Dates

Keywords

Greenlane Holdings, common stock, selling stockholders, warrants, pre-funded warrants, resale, PIPE, offering, securities, distribution, Nasdaq, GNLN